Carlo de Notaristefani
Direktor/Vorstandsmitglied bei Medarex, Inc.
Aktive Positionen von Carlo de Notaristefani
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Direktor/Vorstandsmitglied | 02.09.2009 | - |
Karriereverlauf von Carlo de Notaristefani
Ehemalige bekannte Positionen von Carlo de Notaristefani
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Geschäftsführer | 01.08.2012 | 02.10.2019 |
Corporate Officer/Principal | 18.02.2013 | 27.02.2013 | |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2004 | 01.07.2011 |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2001 | - |
Ausbildung von Carlo de Notaristefani
Università degli Studi di Napoli Federico II | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Italien | 2 |
Israel | 2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
- Börse
- Insiders
- Carlo de Notaristefani
- Erfahrung